Evidence map›Paper›PMID 36387994›Full record

ArticleContemporary clinical trials communications2022

Effectiveness of an online support program to help female cancer patients manage their health and illness: Protocol for a randomized controlled trial.

Michiyo Mizuno, Ikuko Chiba, Toru Mukohara, Miki Kondo, Kazushi Maruo, Tomohiro Ohigashi, Miki Naruo, Yoshihiro Asano, Tatsuya Onishi, Hiroshi Tanabe and 10 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Michiyo MizunoInstitute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Ikuko ChibaDepartment of Nursing, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Toru MukoharaDepartment of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Miki KondoDepartment of Nursing, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Kazushi MaruoInstitute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Tomohiro OhigashiDepartment of Biostatistics, Tsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Miki NaruoDoctoral Program in Nursing Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yoshihiro AsanoSchool of Medicine and Health Sciences, Shinshu University, Matsumoto, Nagano, Japan.
Tatsuya OnishiDepartment of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Hiroshi TanabeDepartment of Gynecology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Rieko MutaSchool of Medicine and Health Sciences, Shinshu University, Matsumoto, Nagano, Japan.
Saori MishimaDepartment of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Susumu OkanoDepartment of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Masami YudaDepartment of Nursing, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Ako HosonoDepartment of Pediatric Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Yuri UedaDepartment of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
Hiroko BandoInstitute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Hiroya ItagakiInstitute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Carol Estwing FerransDepartment of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, Illinois, USA.
Tetsuo AkimotoExploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan.
National Cancer Center Hospital East · JPUniversity of Tsukuba · JPShinshu University · JPChiba Cancer Center · JPTokyo Medical University · JPUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The aim of the trial is to evaluate the effectiveness of interventions provided by online support program apps, adopting health-related quality of life (HR-QOL) scores as indicators. Methods: The design is as an open, randomized, parallel-group trial with longitudinal data collection. The subjects will be female cancer patients receiving treatment in a Japanese National Cancer Hospital. Patients assigned to the experimental group will use three apps: an app for them to monitor their own health (monitoring app), an app to assess their understanding of their diagnosis and treatment and their readiness to receive treatment (confirmation app), and an app to address mental health issues (writing app); patients assigned to the control group will use only the monitoring app. At baseline (before patients undergo cancer treatment) and three other times during the study, evaluation indicators will be obtained from three different standardized HR-QOL scales that are incorporated in the monitoring app. The study hypothesis is that at 6 months after patients' baseline health monitoring, patients in the experimental group will have improved HR-QOL as compared with patients in the control group. Conclusion: This study is based on self-regulation theory, so it is important that the online support program works in an efficient way with respect to patients finding and setting their own health-related goals and adapting their behaviors to achieve those goals. Verifying the effectiveness of the combination of the three apps will show that it is a scientifically valid approach to maintaining or improving the HR-QOL of cancer patients.

Indexed as

eHealthFemale cancer patientsHealth-related quality of lifeRandomized controlled trial

Identifiers

PMID36387994
PMCPMC9661427
OpenAlexW4309411399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.